1. Home
  2. CHE vs KRYS Comparison

CHE vs KRYS Comparison

Compare CHE & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CHE

Chemed Corp

N/A

Current Price

$403.53

Market Cap

5.6B

Sector

Health Care

ML Signal

N/A

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$257.49

Market Cap

7.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHE
KRYS
Founded
1970
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
7.8B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
CHE
KRYS
Price
$403.53
$257.49
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$498.00
$297.60
AVG Volume (30 Days)
225.1K
252.1K
Earning Date
06-02-2026
05-18-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
128.00
EPS
18.34
6.84
Revenue
$2,529,978,000.00
$389,130,000.00
Revenue This Year
$6.60
$40.88
Revenue Next Year
$6.15
$35.16
P/E Ratio
$21.88
$37.83
Revenue Growth
4.06
33.94
52 Week Low
$385.00
$123.03
52 Week High
$623.61
$298.30

Technical Indicators

Market Signals
Indicator
CHE
KRYS
Relative Strength Index (RSI) 35.57 43.41
Support Level $385.00 $255.65
Resistance Level $462.68 $293.60
Average True Range (ATR) 13.12 9.56
MACD -5.03 -1.70
Stochastic Oscillator 19.07 22.40

Price Performance

Historical Comparison
CHE
KRYS

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: